RGNX
Regenxbio Inc
7.40$
+2.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 57.7% | 58.4% | 62.8% | 60.9% | 60.4% | 59.7% | 63.8% | 64.3% | 63.2% | 62.1% | 54.6% | 61.1% | |
| 8.4% | 6.0% | 18.0% | 10.1% | 10.9% | 12.3% | 26.5% | 13.7% | 11.2% | 7.6% | 4.5% | 9.4% | |
| 47.6% | 48.0% | 53.8% | 51.0% | 49.2% | 50.4% | 54.6% | 55.6% | 52.2% | 50.8% | 44.0% | 27.3% | |
| 5.0% | 4.6% | 2.8% | 4.2% | 4.9% | 4.6% | 3.9% | 3.7% | 5.0% | 6.0% | 3.2% | 27.6% | |
| 2.0% | – | 0.0% | – | -2.4% | – | – | – | – | – | – | – | |
| 42.7% | 45.7% | 37.9% | 38.8% | 41.9% | 44.3% | 44.1% | 63.2% | 69.3% | 77.3% | 93.8% | 81.4% | |
| 20.1% | 22.7% | 17.5% | 17.3% | 19.8% | 22.1% | 21.7% | 20.6% | 23.7% | 26.1% | 20.8% | 21.4% | |
| 1.0% | 1.2% | 7.3% | 6.9% | 1.5% | 1.7% | 1.6% | 1.4% | 9.7% | 10.6% | 2.3% | 1.9% | |
| 3.4% | 4.0% | 5.0% | 2.9% | 3.8% | 4.9% | 3.9% | 3.7% | 4.2% | 4.7% | 6.2% | 4.0% | |
| 57.3% | 54.3% | 62.1% | 61.2% | 58.1% | 55.7% | 55.9% | 36.8% | 30.7% | 22.7% | 6.2% | 18.6% | |
| -101.3% | -122.8% | -122.1% | -144.3% | -169.7% | -200.0% | -188.6% | -171.6% | -201.6% | -248.6% | -355.7% | -308.7% | |
| 6.9% | 7.7% | 7.3% | 8.9% | 9.8% | 10.9% | 10.5% | 8.9% | 9.8% | 11.4% | 15.3% | 13.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.